HHS to provide $23 million to Merck for Ebola vaccine production
FILE PHOTO: A health worker fills a syringe with Ebola vaccine before injecting it to a patient, in Goma, Democratic…
Trump administration to appeal ruling blocking price disclosure for drug ads
FILE PHOTO: Bottles of drugs sit on the shelf at the Rock Canyon Pharmacy, in Provo, Utah, U.S., May 9,…
Teva launches generic version of EpiPen for young children
(Reuters) – Teva Pharmaceutical Industries Ltd on Tuesday made its generic version of Mylan’s EpiPen for young children available in…
Cardinal Health warns ongoing opioid-related lawsuits to hit business
(Reuters) – Drug distributor Cardinal Health Inc (CAH.N) warned on Tuesday that its business could be hurt as it defends…
FDA declines to approve Sarepta’s second Duchenne treatment
(Reuters) – Sarepta Therapeutics Inc said on Monday the U.S. Food and Drug Administration declined to approve its newest treatment…
Roche’s personalized cancer treatment wins FDA approval
FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in…
Surgeons not good at predicting benefit from knee operations
(Reuters Health) – Surgeons are no better at determining which patients might benefit from operations to treat torn knee cartilage…
Disparities in access to best stroke treatment
(Reuters Health) – Less than 10% of U.S. stroke patients get a treatment that evidence shows is most effective for…
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
AbbVie prices new rheumatoid arthritis drug at $59,000 a year
(Reuters) – AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on…
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
Edwards Lifesciences, Medtronic heart valves win FDA approval for expanded use
(Reuters) – Heart valve systems from Edwards Lifesciences Corp and Medtronic Plc have been approved for use in a condition…
FDA approves Celgene’s bone marrow cancer treatment
(Reuters) – The U.S. Food and Drug Administration on Friday approved Celgene Corp’s Inrebic to treat certain rare forms of…
AbbVie prices new rheumatoid arthritis drug at $59,000/yr
(Reuters) – AbbVie Inc has priced its new rheumatoid arthritis treatment at $59,000 a year after gaining U.S. approval on…
U.S. FDA approves TB Alliance’s treatment for drug-resistant tuberculosis
(Reuters) – The U.S. Food and Drug Administration has approved TB Alliance’s treatment for drug-resistant tuberculosis as part of a…
Novartis replaces top scientists at Avexis after drug data manipulated
NEW YORK (Reuters) – Novartis AG said on Wednesday it replaced the two top research and development executives at its…
Novartis names Bulto as new head of U.S. drugs business
FILE PHOTO: Logo of Swiss drugmaker Novartis is seen at its branch in Schweizerhalle near Basel, Switzerland, March 29, 2018.…
Novartis says top R&D executives no longer at Avexis unit after test data manipulation
FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland…
Amgen wins U.S. patent battle on arthritis drug Enbrel, thwarting Novartis
(Reuters) – A U.S. judge on Friday upheld two patents relating to Amgen Inc’s blockbuster rheumatoid arthritis drug Enbrel, denying…
No-deal Brexit could deepen Europe’s shortage of medicines – experts
BRUSSELS (Reuters) – As the Oct. 31 deadline for Britain to leave the European Union approaches, health professionals are warning…
U.S. records 10 new cases of measles last week
FILE PHOTO: A vial of the measles, mumps, and rubella (MMR) vaccine is pictured at the International Community Health Services…
Regeneron’s Ebola treatment proves superior to rival in trial
(Reuters) – Regeneron Pharmaceuticals Inc said on Monday its experimental treatment for Ebola proved superior to a rival therapy from…
Senator Grassley seeks info on Novartis’s Zolgensma data issues
FILE PHOTO: U.S. Senator Chuck Grassley (R-IA) speaks to reporters on his way from the Senate floor after a vote…
Scientists hail promise of first effective Ebola treatments in Congo trial
LONDON (Reuters) – Scientists are a step closer to finding the first effective treatments for the deadly Ebola haemorrhagic fever…
Sarepta says adverse event report for DMD gene therapy erroneously submitted
(Reuters) – Sarepta Therapeutics Inc said on Thursday it was informed that an adverse event report was erroneously submitted to…
FDA panel backs Gilead’s HIV prevention drug Descovy, except in women
(Reuters) – An FDA advisory panel on Wednesday voted in favor of Gilead Sciences Inc’s combination drug to reduce the…
Patient groups push back against Gilead’s pricey HIV prevention treatment
LOS ANGELES (Reuters) – Gilead Sciences Inc (GILD.O) hopes to soon introduce a pricey new pill to prevent HIV in…
Medicare to cover expensive cancer cell therapies
FILE PHOTO: A Gilead Sciences, Inc. office is shown in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen Lam (Reuters)…
Drug industry urges Canada to act early on U.S. import plan
TORONTO (Reuters) – Canada’s main pharmaceutical lobby group has urged the government not to wait for drug shortages before responding…
Roche says test showed Tecentriq helped vs bladder cancer
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
U.S. recorded eight new cases of measles last week
FILE PHOTO: A vial of the measles, mumps, and rubella (MMR) vaccine is pictured at the International Community Health Services…
More than 1 in 10 U.S. elderly are binge drinkers
(Reuters Health) – – Binge drinking, often associated with young adults, isn’t as rare as some might think among older…
U.S. FDA approves Daiichi Sankyo’s treatment for rare joint tumor
(Reuters) – The U.S. Food and Drug Administration on Friday approved Daiichi Sankyo Co Ltd’s treatment for adult patients with…
Thailand set to deliver first batch of medical marijuana
BANGKOK (Reuters) – Thailand plans to distribute about 10,000 bottles of cannabis oil next week for hospital patients, a government…
Rwanda says its border with Congo remains open
Congolese people walk near the gate barriers at the border crossing point with Rwanda following its closure over Ebola threat…
Rwanda border with Ebola-hit Congo fully open after slowdowns: minister
KIGALI/GOMA, Democratic Republic of Congo (Reuters) – Rwanda’s border with Ebola-hit Democratic Republic of Congo was fully open late on…
Second Ebola case in Congo’s main eastern city dies
GOMA, Democratic Republic of Congo (Reuters) – The second patient to be diagnosed with Ebola in eastern Congo’s main city…
Trump firms up plan to import medicines; pharma companies resist
(Reuters) – The Trump administration took a step Wednesday toward allowing importation of medicines from Canada, an action the president…
Oklahoma makes final bid to hold J&J responsible for opioid epidemic
(Reuters) – Oklahoma’s attorney general on Wednesday made his final bid to force Johnson & Johnson to pay $17 billion…
Bernie Sanders visits Canadian pharmacy, talks drug prices
WINDSOR, Ontario (Reuters) – U.S. Senator and Democratic presidential hopeful Bernie Sanders joined diabetes patients as they drove across the…
European panel okays GW Pharma cannabis drug for epilepsy
(Reuters) – GW Pharmaceuticals’ marijuana-based treatment Epidyolex has won a positive recommendation for marketing approval from a European Medicines Agency…
Bayer in frame to win first EU nod for high-precision cancer drug
(Reuters) – Europe’s drug regulator has recommended approving Bayer’s Vitrakvi, putting the medicine on track to become the first in…
WHO says it could use more U.S. help on the ground in Ebola fight
GENEVA (Reuters) – The United States could bolster the battle against the Ebola virus in Democratic Republic of Congo by…
Sanofi ends partnership with Lexicon to develop diabetes drug
FILE PHOTO: A logo of Sanofi is pictured during the company’s shareholders meeting in Paris, France, April 30, 2019. REUTERS/Benoit…
Allergan recalls textured breast implants worldwide
(Reuters) – Allergan Plc said on Wednesday it was recalling its Biocell textured breast implants and tissue expanders across markets,…
Many deadly common cancers get little charity funding
(Reuters Health) – Many of the most common and lethal cancers get the fewest research dollars from fundraising advocacy groups,…
Bristol-Myers releases mixed Opdivo lung cancer results
FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage,…
Eli Lilly’s hypoglycemia treatment wins FDA approval
FILE PHOTO: The logo of Lilly is seen on a wall of the Lilly France company unit, part of the…
Exclusive: White House preparing order that would cut drug prices for Medicare: sources
NEW YORK (Reuters) – U.S. President Donald Trump is considering a sweeping executive order that would cut prices on virtually…
Drug makers met with Trump to argue against Senate pricing bill
(Reuters) – The main pharmaceutical industry lobbying group said on Thursday it and some drugmakers met with President Donald Trump…
Deployment of second Ebola vaccine would not be quick fix, experts warn
GOMA, Democratic Republic of Congo (Reuters) – The resignation of Congo’s health minister in the midst of the country’s worst…
Prevagen maker must face FTC, New York claims that memory supplement does not work
NEW YORK (Reuters) – Quincy Bioscience failed to dismiss a lawsuit in which the Federal Trade Commission and New York…
Sanofi signs U.S. rights deal with Roche for flu treatment Tamiflu
FILE PHOTO: A logo of Sanofi is pictured during the company’s shareholders meeting in Paris, France, April 30, 2019. REUTERS/Benoit…
Senators announce bipartisan proposal to lower drug prices
WASHINGTON/NEW YORK (Reuters) – The top Republican and Democrat on the U.S. Senate Finance Committee announced a proposal to lower…
Multiple sclerosis drug helps Biogen beat Wall St. profit expectations
(Reuters) – Biogen Inc reported better-than-expected second quarter profit and raised its 2019 earnings forecast on Tuesday, driven by higher…
Senators announce bipartisan proposal to lower drug prices
WASHINGTON/NEW YORK (Reuters) – The top Republican and Democrat on the U.S. Senate Finance Committee announced a proposal to lower…
Multidrug-resistant malaria spreading in Southeast Asia: study
FILE PHOTO: Anopheles minimus mosquitoes are pictured at a lab in the Public Health Ministry in Bangkok, Thailand, November 9,…
Novartis’s older MS drug Gilenya wins Chinese approval
FILE PHOTO: Swiss drugmaker Novartis’ logo is seen at the company’s plant in the northern Swiss town of Stein, Switzerland…
WHO says investigators conclude Ebola victim did not enter Rwanda
GENEVA (Reuters) – A Congolese woman who may have spread the deadly Ebola virus in Uganda did not go to…